Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
War on Drugs: New CPT codes for screening and RX
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Recommended
Details
Presenters
Overview
Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
Advances in Women's Health
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
<p>Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients</p>
Advances in Women's Health
Reducing the Risk of Postpartum Depression Through Sleep Interventions
<p>Reducing the Risk of Postpartum Depression Through Sleep Interventions<strong> </strong></p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?